The Northern Ireland-based company offers digital pathology software applications for research, education, and biopharma markets. Their solutions improve diagnosis quality, enable pathologists to review and share clinical data, and ultimately enhance patient outcomes. PathXL's expertise in digital pathology image analysis and educational tools has positioned them as a leader in this fast-growing field. In July 2020, PathXL was acquired by Cirdan, although the terms of the transaction were not disclosed.